Paul Craddy founded Remap Consulting in January 2014 to help clients optimise their pricing, health economics and market access outcomes.
Prior to that, Paul was Head of Diabetes for Pricing, Market Access and Health Economics for EUCAN within Takeda Pharmaceuticals. In this role, Paul was responsible for leading the franchise including managing the launch of a new diabetes therapy, providing input into R&D for pipeline products and optimising in-market products. Paul was also a member of the PMAHE management team, helping set the strategic direction of the PMAHE department.
During his time in Nycomed, Paul led the strategic pricing team responsible for global pricing decisions for Nycomed’s global brands. He was also a core member of the PMAHE integration team during the Takeda takeover, helping to design and implement the new PMAHE organisation within Takeda.
Preceding Nycomed, Paul was a PMA consultant with IMS Consulting based in Cambridge, UK. Here, he managed numerous global PMA projects across a variety of international clients, developing launch pricing strategies, creating payer value propositions & communications and managing market access reorganisations.
Paul holds a PhD in molecular biology from Edinburgh University and has a BSc Biology from Manchester University.
With over 20 years pharmaceutical experience, within both consultancy and pharmaceutical companies, Graham brings expertise in embedding market access drivers into clinical development programme; developing global product launch pricing strategies and producing HTA submissions to address payers’ pricing and reimbursement requirements.
Graham’s industry experience includes GSK, start-up biotech companies and Ferring pharmaceuticals. During his time at Ferring Graham was Global Head of Market Access and Pricing taking responsibility for all market access activities from incorporation of payer value into clinical development programs through to development and implementation of the market access and pricing strategy for global product launches.
Graham’s consultancy experience was obtained within both IMS consulting (previously Cambridge Pharma) and Adelphi Values whereby he was responsible for global pricing and reimbursement projects ranging from strategic insights to global pharmaceutical companies; market access training to senior management and affiliates; development of biosimilar access strategies and EU pricing and reimbursement submissions.
Graham has worked across many therapeutic areas including Oncology, Gastroenterology, Urology, Fertility, Obstetrics and Endocrinology.
Graham has a Ph.D. in neuropharmacology from Durham University and an MBA from Aston University. He currently lives in near Manchester, UK.
Charlie has 10 years of experience in the pharmaceutical industry, split between both consultancy and NICE. Prior to joining Remap Consulting, Charlie worked at a pharmaceutical market research agency and a healthcare strategy consulting company, acting as the main client lead on life science consultancy projects for companies ranging from small biotech to large global pharma. Charlie also spent over 2 years working in NICE’s technology appraisals team, where he led the development of committee materials and guidance documents across a wide range of therapy areas.
Charlie is experienced in managing pricing and market (PMA) access projects for pharmaceutical and biotech clients, including pricing and reimbursement landscape analyses, health technology assessment (HTA) dossier development, HTA scientific advice (both parallel and individual), payer advisory boards and interviews, value proposition and value dossier development, pricing strategies and training materials. Charlie has PMA expertise across a range of therapy areas and topics, including psoriasis, ulcerative colitis and Crohn’s disease, biosimilars, multiple myeloma and DLBCL.
Charlie has an MSc in Biomaterials and Tissue Engineering from University College London, and a BSc in Biological Sciences from the University of Warwick.
Darja has over 12 years of consultancy experience in the field of pharmaceutical pricing and market access. She is experienced in managing global PMA projects such as strategy development for new brands, development of defence strategies for brands facing generic competition, development and validation of phase III clinical trial programmes, development and validation of payer value propositions, and organising and delivering advisory boards. Darja has experience across various therapy areas including neurology, oncology, antibiotics and cardiology.
Prior to joining Remap, Darja was a Principal at Evidera within their Global Market Access Consulting practice where she managed numerous global PMA engagements.
Darja has a PhD in Molecular Biology from Imperial College London, specialising in Obesity and Metabolic Disorders. She also holds a BSc in Genetics from Queen Mary, University of London.
Hannah has extensive experience in the pharmaceutical industry, having started her career with AstraZeneca and then going on to hold roles with two other well-established consultancies before joining Remap as Associate Director in 2019.
Hannah’s experience in delivering Global PMA projects spans multiple therapy areas and includes deliverables such as HTA submissions, real world evidence, value demonstration, advisory boards, payer research and pricing.
Hannah has a Master of Pharmacy degree from the University of Nottingham and completed her pharmacist pre-registration training with University Hospitals of Leicester and AstraZeneca.
Lucy has extensive experience in the field of life sciences consulting.
Lucy is experienced in leading and managing engagements across a range of global pricing and market access projects such as value proposition development, rapid BD assessment, pricing strategy development, launch planning, market access strategy development, analogue assessment, client team training program development and advisory boards.
Lucy has a particular interest in rare diseases and has extensive experience on the pricing and access pathways for orphan products.
Claire brings more than twenty years of experience in the pharmaceutical industry in roles spanning clinical research, sales & account management and market access.
Prior to joining Remap, Claire spent over eight years in the Value Development Team at The Medicines Company. In her role as Head of Value for Europe, she led reimbursement and access activities for six products; developing the reimbursement strategies for each product, demonstrating their economic value in European launch markets, and removing reimbursement hurdles for launch or acquisition.
As Engagement Manager at IMS Consulting Group, Claire led global pricing, reimbursement and market access projects across the entire lifecycle from early product development to patent expiry, for both small biotech and large pharmaceutical clients.
Her early career was spent first in clinical research for Bristol-Myers Squibb in their HIV, immunology and cardiovascular development areas and later in sales and account management for BMS and IMS.
Mike is a consultant who is proficient in working with clients to understand and provide solutions to their market access problems.
Over the last four years at Remap Consulting, he has gained significant experience in managing projects, from rapid-fire commercial assessments, payer research programs, structural re-organisation and HTA submissions. Additionally, Mike has developed expertise in the development and delivery of training of complex market access and pricing topics.
Mike has been involved on projects covering a diverse range of healthcare topics, particularly in dermatology, rare diseases and endocrinology.
Prior to joining Remap Consulting, Mike was a Medical Affairs Operations Executive at ViiV Healthcare, working in projects involving digital clinical data tools, medical affairs governance and process improvement initiatives
Mike has a BSc in Pharmacology from the University of Leeds.
Tania is an expert in pricing and market access with more than 13 years of experience in the pharmaceutical sector. Ranging from biotech companies such as Clovis Oncology to big pharma including Sanofi and Takeda, she has worked in a variety of organizations at international and national levels leading the access strategy for products in oncology, gastroenterology, immunology, respiratory and inflammatory diseases.
Tania leverages her experience and profound knowledge of the market access decision-making, HTA processes and pricing negotiations to disentangle the complex issues faced by pharmaceutical organizations.
Tania has a deep interest in the challenges linked to rare diseases and to healthcare reform.
Ben has 14 years’ experience in market access for emerging markets and has delivered more than 100 projects since 2010. His main areas of expertise include local market access dossier customisation, stakeholder research and landscaping, pricing studies and payer negotiation simulations.
Ben has worked extensively in Latin America, Asia-Pacific, Middle East & Africa and Eastern European countries, with a particular focus on the BRICMT markets and high-growth developing economies worldwide. He has worked in all major therapy areas, including oncology, diabetes, respiratory medicine and innovative vaccines.
Fluent in Spanish and Portuguese, Ben holds a Master’s degree from Oxford University.
Andreas has more than 20 years of industry experience in health care, having worked on Market Access and P&R in Germany, France, UK and Switzerland. Andreas gained his industry experience at Allergan, Lilly, BIOGEN and Medtronic. Andreas also worked as Director Outcomes Research at NHS Innovations, London and gave lectures on Market Access at the University of Lyon and Paris and the European Business School (EBS) in Oestrich-Winkel.
Andreas is regularly invited as an expert speaker on conferences around Market Access and as a member of advisory board panels to the pharmaceutical industry. He is the founder of the “European Journal of Health Economics”.
Andreas and Remap Consulting have collaborated on a wide range of pricing and market access projects, including payer advisory boards and payer scientific advice meetings.
Kate brings over twelve years of healthcare experience in both consulting and industry roles. She was most recently responsible for building the Medical Affairs business and strategic function at Spero Therapeutics. Prior to that, she led Value (Economics, Reimbursement, and Market Access) for the Infectious Disease franchise at the Medicines Company, where she supported Value development and value-based pricing for two novel pharmaceuticals and one re-launch under an sNDA.
In her consulting roles, Kate’s experience spanned health economics and outcomes research, patient-reported outcomes, pricing, market access, and real-world evidence development across multiple pharmaceutical, device, and diagnostic manufacturers.
Kate holds dual bachelor’s degrees from Brown University and a Master of Public Health degree from Columbia University’s Mailman School of Public Health. She is based in the greater Boston, MA area.
Leslie has substantial clinical and academic experience, is committed to the highest standards and is capable of facilitating the provision of bespoke solutions to clients’ pricing and market access needs.
Leslie is a medical doctor with over nine years of clinical experience. Upon completion of her medical degree at the National Autonomous University of Mexico, she specialised in Otolaryngology-Head and Neck Surgery. During her years of clinical practice in Mexico, she gained experience working in secondary and tertiary care across the different national healthcare subsystems.
Prior to joining Remap, she completed a masters degree in Translational Medicine and a Ph.D. in Genomics from the University of Manchester. Whilst based in the multidisciplinary environment of the North West Genomic Laboratory Hub (NHS), Leslie developed several research skills and expanded her knowledge on a breadth of genetic rare disease disorders and the role of genomic strategies in precision medicine.
Lauren is an analyst with ample academic experience and is dedicated to providing a high working standard to facilitate client needs. She has experience in pricing research, competitive landscape analysis, analogue analysis as well as in supporting the creating of materials for early scientific advice and global value dossiers.
Prior to joining Remap Consulting Lauren gained experience in several client facing roles. Her time at DRG Abacus has provided her with a grounding in market access and an understanding of client requirements. Moreover, whilst studying Lauren took on extra roles allowing her to gain experience in creating, co-ordinating and delivering training materials.
Lauren obtained a first-class degree in Biology at the University of York and went on to gain a masters and Ph.D. from The National Heart and Lung Institute at Imperial College London where she focused on the molecular responses after cardiac injury. During this time Lauren gained significant academic experience, expanding her knowledge of cardiac diseases and research techniques.
Lauren is an analyst with substantial experience in client-facing roles, allowing her to effectively understand and address client needs.
Prior to joining Remap Consulting Lauren gained experience working and researching on a diverse range of healthcare projects in areas including rare disease, neurology and oncology during her time at University.
Whilst in academia, Lauren participated in extracurricular activities allowing her to gain experience in collating, coordinating and communicating materials. In addition, her prior experience in the health and care sector have developed her understanding of challenges faced within the industry, such as the importance of knowledge dissemination and influence of health policy in getting drugs to market. Both have benefitted Lauren in her project work on value propositions, HTA analysis and landscape assessments.
Lauren holds a BSc in Natural Sciences specialising in Biology and a Masters in Public Health both from The University of York.
Michael is an analyst with previous experience in client-focussed roles, allowing him to be effective in assessing and understanding clients’ problems to provide the best solutions.
Prior to joining Remap, Michael obtained a first-class Master’s degree in chemistry from the University of York which included a year in industry at GSK. During this time, he worked within their Chemical Biology department, helping to develop technologies to aid in preclinical research for hit molecule determination. Michael gained valuable experience of the pharmaceutical industry and insight into the drug development process as well as extensive data analysis skills.
Giulia is an analyst with extensive experience across multiple client-facing sectors, enabling her to understand how to best address different clients’ needs.
Prior to joining Remap, Giulia achieved a Master’s Degree in Philosophy, Politics and Economics of Health at UCL, where she focused on HTA processes and the cross-country variation in the value assessments of drugs and medical devices. She is also trained in critical appraisals of both primary and secondary research, including systematic reviews and hence has a comprehensive understanding of evidence evaluation.
In addition, Giulia has a thorough understanding of a variety of economic evaluations, such as cost-effectiveness analysis, including cost-utility analysis. Similarly, she has gained experience in the collection of Patient- Reported Outcomes including the challenges involved in the face and content validity of their measures.
Julia is an analyst whose extensive experience in client-oriented roles allow her to efficiently assess clients’ needs and provide professional assistance.
During her time at university, Julia gained valuable insight into all stages of drug design and development. She sharpened her primary and secondary research skills on projects from areas including biocatalysis for drug development and metabolomics in disease diagnostics. As an avid educator with an analytical mind, Julia is passionate about finding the most effective ways of communicating complex data and ideas.
Julia studied Chemistry with Medicinal Chemistry at the University of Manchester and is awaiting to graduate with First Class Bachelor’s degree this September.
Vishal is an analyst with prior experience in client-facing roles, enabling him to effectively assess and accommodate clients’ needs.
During Vishal’s time at university, he contributed to research into cerebral small vessel disease, developing a variety of skills in both primary and secondary research. This experience also helped Vishal to gain the knowledge to perform systematic literature reviews, generate reports and presentations, and to work as part of a research team. Furthermore, Vishal gained valuable experience into data analysis and is summarily passionate about using these skills to the benefit of his clients.
Vishal studied at the University of Manchester where he obtained a first-class MSci degree in Neuroscience.
Sam is an analyst whose prior experience in client-orientated roles, allows him to efficiently understand clients’ needs and provide effective assistance.
Prior to joining Remap Sam completed a BSc in Biochemistry at the University of Bath before going on to obtain a distinction for his master’s degree in Biotechnology and Enterprise at the University of Manchester. Both these academic successes have helped Sam develop his primary and secondary research skills on projects in areas such as scaffold design for regenerative medicine and cancer epigenetics. From this, Sam gained valuable expertise in data analysis and is passionate about applying these skills and experiences to meet the needs of his clients.
During his time at university, Sam participated in extracurricular activities allowing him to gain experience in collaborating, coordinating, and communicating on projects to deliver a valuable outcome.
With over 22 years’ experience working within the pharmaceutical and healthcare consultancy industry, Sarah brings a wealth of experience in training development and design, project management and project support.
Using her extensive design techniques, Sarah creates and delivers visually powerful, interactive market access eLearning training programmes, ensuring content is created to a high standard that adheres to your company brand guidelines and technical specifications.
Sarah’s training expertise includes applying blended instructional design techniques and methodologies using multiple virtual and face-to-face delivery methods including eLearning, classroom-based workshops, interactive PowerPoint presentations and webinars.
Prior to joining Remap Consulting, Sarah gained experience at Adelphi Values and AstraZeneca, providing support for a variety of projects across various therapy areas. Sarah also holds an ISEB qualification in Programme & Project Support Office and an Articulate Storyline accreditation.
Amy is a proactive and achievement-oriented Marketing Manager with a proven track record of delivering successful marketing, brand and social media campaigns that drive conversions and meet organisational objectives.
As an Associate Member of the Chartered Institute of Marketing, Amy holds a Diploma in Professional Digital Marketing and is working towards becoming a Chartered Marketer. She also holds certifications in SEO Best Practise, LinkedIn Marketing and Fundamentals of Digital Marketing.
In addition to managing social media platforms, Amy is proficient in Adobe Creative Suite, Google Analytics, CRM systems and WordPress.
Prior to joining Remap Consulting, Amy gained professional experience at Greene King PLC providing marketing and brand development support for the Hungry Horse commercial team.
Amy also holds a Bachelor of Science in Biochemistry from Sheffield Hallam University.
Charlotte has over 18 years’ experience within the pharmaceutical industry across multiple roles. Within Remap Consulting, she supports projects from an administrative and logistical perspective, both internally and externally.
Charlotte’s expertise lies in market research, specifically secondary data analysis, which includes interpreting, reporting and presenting global brand performance data via a wide variety of commercial information sources and competitive intelligence.
Prior to joining Remap Consulting, Charlotte worked within AstraZeneca in international marketing functions across a range of therapy areas and brand teams.
Isidora joins Remap as a highly skilled experienced presentation designer. She has a love for PowerPoint design and with her strong presentation skills, Isidora creates and delivers visually powerful client ready presentations.
Prior to joining Remap, Isidora applied her skills within the banking industry where she created and executed high level presentations from concept through to completion. Isidora also has strong excel capabilities by creating complex excel charts and delivering training through lunch and learns.
Isidora also gained a BSc in Human Genetics gained at the University College London.
Anita has over 30 years’ experience of working in HR, Employee Relations, line management, project management and training and development.
Much of her experience gained during her time at AstraZeneca working various departments and disciplines.